Rising Denial Rates in Health Insurance: A Barrier to Care

Denial rates for health insurance claims have surged, reaching between 13% and 35% among major insurers. This trend places additional financial strain on patients and raises regulatory concerns. Data from 2021 to 2023 underscores the urgent need for reform.

The Kaiser Family Foundation (KFF) analyzed claims submitted to Affordable Care Act (ACA) marketplace insurers. A Georgia insurer reported a staggering 35% denial rate in 2022, while those in states with stricter regulations averaged around 13%.

Many claim denials arise from coding errors or inadequate documentation. Medical necessity determinations often lack transparency. "Denials for medical necessity remain opaque," said Karen Pollitz, a senior fellow at KFF. "Insurers often provide little to no justification beyond boilerplate language, leaving patients and providers in the dark."

The U.S. Department of Health and Human Services (HHS) reported that fewer than 0.2% of denied claims under ACA marketplace plans were appealed in 2022. Among those appeals, 40% were overturned in favor of patients. Despite this reversal rate, the low appeal rate highlights significant barriers. "Patients often lack the time, resources, or knowledge to navigate the appeals process," noted Pollitz. "The system is designed in a way that disproportionately disempowers the individual."

Denied claims can impose severe financial burdens. Patients may be forced to pay out-of-pocket for treatments they assumed were covered. A 2023 survey by the Commonwealth Fund found that 30% of Americans delayed healthcare due to cost concerns, with many attributing these delays to insurance denials.

Insurers defend their denial rates as necessary for fraud prevention. In a statement to Bloomberg, AHIP (America’s Health Insurance Plans) asserted, "Denials serve an essential function in maintaining the integrity of the system by ensuring that services meet evidence-based standards." Critics argue that this rationale often dismisses legitimate claims rejected for minor issues.

State regulations further complicate the landscape. California and New York mandate detailed disclosure of denial reasons and independent reviews, while other states lack these protections. "It’s a regulatory uneven playing field," said Sabrina Corlette, co-director at the Center on Health Insurance Reforms at Georgetown University. "Where you live can dramatically affect the likelihood of a denial and your options for recourse."

Pressure is mounting for federal action. HHS has proposed rule changes to standardize denial reporting and enhance patient protections in ACA-compliant plans. If enacted, insurers would need to publicly disclose denial metrics and improve transparency around appeals. Industry groups may resist these changes, citing administrative burdens.

Patient advocacy organizations are urging immediate reforms, focusing on educating patients about their rights under existing laws, including the No Surprises Act of 2022. This legislation addresses out-of-network billing practices but does not directly tackle claim denials. "We’re tackling an iceberg," said Sara Collins, vice president at the Commonwealth Fund. "Insurance practices are just one piece of a much larger issue of healthcare affordability."

The consequences of inaction could be severe. Rising denial rates threaten to erode trust in the insurance system and exacerbate health inequities. Marginalized communities, facing high uninsured rates, are particularly at risk. The connection between insurance coverage and health outcomes emphasizes the urgency of these reforms.

Whether insurers, regulators, and policymakers can recalibrate the system to balance cost containment with equitable access remains uncertain. For millions of insured Americans, the promise of coverage increasingly comes with fine print that is harder to navigate. As Corlette summarized, "Insurance is supposed to be a shield against financial ruin. For many, it’s becoming a maze instead."